Allarity Therapeutics Inc. (NASDAQ: ALLR) Stock Information | RedChip

Allarity Therapeutics Inc. (NASDAQ: ALLR) Listen to this Section


$0.16
+0.0033 ( +2.10% ) 1.2M

Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.

Market Data


Open


$0.16

Previous close


$0.16

Volume


1.2M

Market cap


$6.89M

Day range


$0.15 - $0.17

52 week range


$0.14 - $40.60

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 78 Aug 05, 2024
8-k 8K-related 15 Jul 23, 2024
8-k 8K-related 13 Jul 22, 2024
def Proxies and info statements 4 Jul 01, 2024
ars Annual reports 1 Jul 01, 2024
8-k 8K-related 15 Jun 28, 2024
8-k 8K-related 15 Jun 26, 2024
8-k 8K-related 13 Jun 21, 2024
pre Proxies and info statements 4 Jun 21, 2024
8-k 8K-related 14 Jun 06, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.